Skip to main content
Log in

Toxic Epidermal Necrolysis Induced by a Triple-Drug Regimen for Helicobacter Pylori Eradication

  • Case Report
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Gasbarrini A, De Luca A, Fiore G, et al. Beneficial effects of Helicobacter pylori eradication on migraine. Hepatogastroenterology 1998; 48: 765–70

    Google Scholar 

  2. Zentilin P, Savarino V, Garnero A, et al. Is Helicobacter pylori infection a risk factor for disease severity in rheumatoid arthritis? Gastroenterology 1999; 116: 503–4

    Article  PubMed  CAS  Google Scholar 

  3. Seriolo B, Cutolo M, Zentilin P, et al. Helicobacter pylori infection in rheumatoid arthritis. J Rheumatol 2001; 28: 1195–6

    PubMed  CAS  Google Scholar 

  4. Aragona P, Magazzu G, Macchia G, et al. Presence of antibodies against Helicobacter pylori and its heat-shock protein 60 in the serum of patients with Sjögren’s syndrome. J Rheumatol 1999; 26: 1306–11

    PubMed  CAS  Google Scholar 

  5. Melby KK, Kvien TK, Glennas A. Helicobacter pylori — a trigger of reactive arthritis? Infection 1999; 27: 252–5

    Article  PubMed  CAS  Google Scholar 

  6. Razavi B. Reactive arthritis after Helicobacter pylori eradication. Lancet 2000; 355: 720

    Article  PubMed  CAS  Google Scholar 

  7. Ridker PM, Hennekens GH, Buring JE, et al. Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, Herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women. Ann Intern Med 1999; 131: 573–7

    PubMed  CAS  Google Scholar 

  8. Gasbarrini A, Franceschi F, Tartaglionse R, et al. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1999; 352: 878

    Article  Google Scholar 

  9. Radenhausen M, Schulzke JP, Geilen CC, et al. Frequent presence of Helicobacter pylori in chronic urticaria. Acta Derm Venereol 2000; 80: 48–9

    Article  PubMed  CAS  Google Scholar 

  10. Farkas H, Fust G, Fekete B, et al. Eradication of Helicobacter pylori and improvement of hereditary angioneurotic oedema. Lancet 2001; 358: 1695–6

    Article  PubMed  CAS  Google Scholar 

  11. Cicconi V, Carloni E, Franceschi F, et al. Disappearance of antiphospholipid antibodies syndrome after Helicobacter pylori eradication. Am J Med 2001; 111: 163–4

    Article  PubMed  CAS  Google Scholar 

  12. Kountouras J, Mylopoulos N, Chatzopoulos D, et al. Eradication of Helicobacter pylori may be beneficial in the treatment of chronic open-angle glaucoma. Arch Intern Med 2002; 162: 1237–44

    Article  PubMed  Google Scholar 

  13. Salimi-Khayati A, Sharami H, Mansour-Ghanaei F, et al. Helicobacter pylori seropositivity and the incidence of hyperemesis gravidarum. Med Sci Monit 2003; 9: CR12–5

    PubMed  Google Scholar 

  14. Garcia-Doval I, LeCleach L, Bocquet H, et al. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Arch Dermatol 2000; 136: 323–7

    Article  PubMed  CAS  Google Scholar 

  15. Wolkenstein P, Revuz J. Toxic epidermal necrolysis. Dermatol Clin 2000; 18: 485–95

    PubMed  CAS  Google Scholar 

  16. Paquet P, Arrese JE, Beguin Y, et al. Clinicopathological differential diagnosis of drug-induced toxic epidermal necrolysis (Lyell’s syndrome) and acute graft-versus-host reaction. Curr Top Pathol 2001; 94: 49–63

    Article  PubMed  CAS  Google Scholar 

  17. Correia O, Delgado L, Ramos JP, et al. Cutaneous T-cell recruitment in toxic epidermal necrolysis. Arch Dermatol 1993; 129: 466–8

    Article  PubMed  CAS  Google Scholar 

  18. Paquet P, Nikkeis A, Arrese JE, et al. Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis. Arch Dermatol 1994; 30: 605–8

    Article  Google Scholar 

  19. Rzany B, Schmitt H, Schopf E. Toxic epidermal necrolysis in patients receiving glucocorticosteroids. Acta Derm Venereol 1991; 71: 171–2

    PubMed  CAS  Google Scholar 

  20. Cox NH. Acute disseminated epidermal necrosis due to omeprazole. Lancet 1992; 340: 857

    Article  PubMed  CAS  Google Scholar 

  21. Miyata T, Yaguchi A, Hashimoto A, et al. Toxic epidermal necrolysis due to omeprazole [in Japanese, abstract in English]. Nishinihon J Dermatol 1996; 58: 574–7

    Article  Google Scholar 

  22. Cattelan AM, Trevenzoli M, Sasset L, et al. Toxic epidermal necrolysis induced by nevirapine therapy: description of two cases and review of literature. J Infect 2001; 43: 246–54

    Article  PubMed  CAS  Google Scholar 

  23. Masia M, Gutierrez F, Jimeno A, et al. Fulminant hepatitis and fatal toxic epidermal necrolysis (Lyell disease) coincident with clarithromycin administration in an alcoholic patient receiving disulfiram therapy. Arch Intern Med 2002; 162: 474–6

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors have no conflicts of interest directly relevant to the content of this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshihiro Matsukawa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matsukawa, Y., Hara, H., Aoki, M. et al. Toxic Epidermal Necrolysis Induced by a Triple-Drug Regimen for Helicobacter Pylori Eradication. Clin. Drug Investig. 24, 301–303 (2004). https://doi.org/10.2165/00044011-200424050-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00044011-200424050-00007

Keywords

Navigation